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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of betaine anhydrous as a feed 
additive for all animal species based on a dossier submitted by Trouw 
Nutritional International B.V.
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Glycine betaine (betaine) acts as a  methyl  group donor in transmethylation reactions  in organisms. Betaine 
occurs in numerous vertebrate tissues as an osmolyte, ensuring osmoprotection. Betaine is safe for piglets at the 
maximum supplementation rate of 2 000 mg/kg complete feed with a margin of safety below 5. This conclusion 
is extended to all pigs and extrapolated to all animal species and categories. The use of betaine as a feed additive 
up to a supplementation of 2 000 mg/kg complete feed is unlikely to pose concerns for consumer safety. In the 
absence of data, betaine anhydrous should be considered  hazardous by inhalation, irritant to skin, eyes and 
mucous membranes and a skin sensitiser. The supplementation of feed with betaine anhydrous does not pose a 
risk to the environment. Betaine has the potential to become efficacious in all animal species and categories 
when administered via feed or water for drinking. The FEEDAP Panel made some recommendations on (i) 
introduction  of  a  maximum  content  for  supplemental  betaine  in  complete  feed  and  water  for  drinking;  (ii) 
avoidance of simultaneous use of betaine in feed and water for drinking; and (iii) avoidance of simultaneous 
inclusion of betaine and choline chloride in premixtures.  
© European Food Safety Authority, 2013 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of betaine anhydrous as a nutritional additive to be used in feed and water for drinking for all 
animal species. 
Glycine betaine (betaine) acts as a methyl group donor in transmethylation reactions in organisms. 
Betaine occurs in numerous vertebrate tissues as an osmolyte, ensuring osmoprotection. 
Betaine is safe for piglets at the maximum supplementation rate of 2 000 mg/kg complete feed with a 
margin of safety below 5. This conclusion is extended to all pigs and extrapolated to all animal species 
and categories. 
The use of betaine as a feed additive up to a supplementation rate of 2 000 mg/kg complete feed is 
unlikely to pose concerns for consumer safety. 
In the absence of data, betaine anhydrous should be considered as hazardous by inhalation, an irritant 
to skin, eyes and mucous membranes and a skin sensitiser. 
The supplementation of feed with betaine anhydrous does not pose a risk to the environment. 
Betaine has a potential to become efficacious in all animal species and categories when administered 
via feed or water for drinking. 
The  FEEDAP  Panel  made  some  recommendations  on  (i)  introduction  of  a  maximum  content  for 
supplemental betaine in complete feed and water for drinking; (ii) avoidance of simultaneous use of 
betaine in feed and water for drinking; and (iii) avoidance of simultaneous inclusion of betaine and 
choline chloride in premixtures. Betaine anhydrous for all animal species 
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BACKGROUND 
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular,  Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7; in addition Article 10(2) of that Regulation also specifies that 
for existing products within the meaning of Article 10(1), an application shall be submitted in 
accordance with Article 7, at the latest one year bef ore the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a 
maximum of seven years after the entry into force of this Regulation for additives authorised without 
time limit or pursuant to Directive 82/471/EEC. 
The European Commission received a request from the  company Trouw  Nutritional International 
B.V.
5 for
 the authorisation of a new use (i.e. use in water for drinking) and the re-evaluation of the 
authorisation of betaine anhydrous, when used as a feed additive for all animal species (category: 
nutritional additive; functional group: vitamins, pro-vitamins and chemically well-defined substances 
having similar effect) under the conditions mentioned in Table 1. 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation 
of an authorised feed additive). EFSA received directly from the applicant the technical dossier in 
support of this application.
6 According to Article 8 of that Regulation, EFSA, after verifying the 
particulars and documents submitted by  the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  16 June 
2011.
7 
Betaine in the form of betaine anhydrous  has been authorised under Council Directive 70/524/EEC
8 
for its use for all animal species as a nutritional additive. 
The Panel on Dietetic Products, Nutrition and Allergies (NDA) issued an opinion related to the use of 
betaine as a novel food in the EU (EFSA, 2005) . The NDA Panel  expressed one opinion on the 
substantiation of health claims related to betaine and contribution to normal homocysteine metabolism 
(ID 4325) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
9 (EFSA, 2011). 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety  for  the  target  animals,  consumer,  user  and  the  environment  and  the  efficacy  of  betaine 
anhydrous, when used under the conditions described in Table 1. 
                                                       
4  Regulation (EC) 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  Trouw Nutritional International B.V., Nijverheidsweg 2, 3881 LA Putten Brussels, The Netherlands. 
6  EFSA Dossier reference: FAD-2010-0253. 
7  A new mandate was received in EFSA in March 2011. 
8  Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. 
9  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9. Betaine anhydrous for all animal species 
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Table 1:  Description and conditions of use of the additive as proposed by the applicant  
Additive   Betaine in the form of Betaine anhydrous 
Registration  number/EC 
No/No  Not appropriate 
Category(ies) of additive  3. Nutritional additives 
Functional group(s) of additive  (a) Vitamins, pro-vitamins and chemically well defined substances having 
a similar effect 
 
Description 
Composition, description  Chemical formula  Purity criteria  Method of analysis 
Betaine anhydrous 
IUPAC name:  
2-
trimethylammonioacetate 
Chemical formula: 
C5H11NO2 
CAS number: 
107-43-7 
Minimum 97 % of 
betaine anhydrous 
produced from 
genetically modified 
sugar beet H7-1          
(KM-ØØØH71-4); 
moisture: max. 1.5% 
HPLC method based 
on ion-exclusion 
chromatography with 
refractive index(RI) 
detection 
 
Trade name   TNIbetain 
Name  of  the  holder  of 
authorisation 
Trouw Nutrition International B.V. 
 
Conditions of use 
Species or 
category of 
animal 
Maximum Age 
Minimum content  Maximum content  Withdrawal 
period 
  mg/kg of complete feedingstuffs  
All animal 
species and 
categories 
No restrictions - 
during all life 
cycle 
Not applicable  Not applicable  Not applicable 
 
Other provisions and additional requirements for the labelling 
Specific conditions or 
restrictions for use   Not appropriate  
Specific conditions or 
restrictions for handling  
For user safety: protective glasses, goggles or shields and approved gloves 
should  be  worn  during  handling.  The  use  of  approved  uniforms  is 
advisable. Handle in accordance with good industrial hygiene and safety 
practices. 
Post-market monitoring   Not appropriate 
Specific conditions for use in 
complementary feedingstuffs   Not appropriate 
 
Maximum Residue Limit (MRL) 
Marker residue  Species or category of animal  Target tissue(s) or 
food products 
Maximum content 
in tissues 
Not appropriate  Not appropriate  Not appropriate  Not appropriate 
 Betaine anhydrous for all animal species 
 
EFSA Journal 2013;11(5):3211  6 
ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution  of  betaine  anhydrous  produced  from  genetically  modified  sugar  beet  H7-
1(KM-ØØØH71-4). It should be recognised that these data cover only a fraction of existing additives 
containing betaine anhydrous. The application is for the active substance and the composition of the 
additive  formulations  is  not  the subject  of  the  application.  The  Panel  has sought  to  use  the  data 
provided together with data from other sources to deliver an opinion. 
1.  Introduction 
Betaines  are  amino  acid  derivatives  in  which the  nitrogen  atom  is fully  methylated, i.e.  they  are 
quaternary ammonium compounds. Glycine betaine is widespread among both flowering plants and 
algae. Sugar beet (Beta vulgaris) contains approximately 0.2–0.3 % glycine betaine (herein referred to 
as betaine). It is also an endogenous compound in animal species. As a methyl group donor, betaine is 
involved in transmethylation reactions in organisms. Betaine occurs in numerous vertebrate tissues as 
an osmolyte (Law and Burg, 1991) ensuring osmoprotection (Clarke et al., 1994; McNeil et al., 1999; 
Pichereau et al. 1999; Xing and Rajashekar, 2001). 
Betaine  anhydrous  is  included  in  the  European  Union  Register  of  Feed  Additives  pursuant  to 
Regulation (EC) No 1831/2003. It is authorised in application of Article 9t (b) of Council Directive 
70/524/EEC
10 concerning additives in feedingstuffs (2004/C 50/01) for use, without a time limit, in all 
animal species as a nutritional additive  and is foreseen for re-evaluation. No maximum contents of 
betaine in feeds are established in the EU. 
The applicant asks for the re-evaluation of the use of betaine anhydrous as an additive to feed and for a 
new use of betaine anhydrous (use in water for drinking) for all animal species and categories.  The 
substance is intended as nutritional additive under the functional group  vitamins, pro-vitamins and 
chemically well-defined substances having similar effects. 
Betaine is used in veterinary medicine as hepatoprotectant in  cattle, pigs, goats, sheep and horses 
(EMEA, 1997). Betaine anhydrous is also designated as an orphan medicinal product (EU/3/01/45) 
and  is  authorised  (Cystadane®)  for  the  adjunctive  treatment  of 
hyperhomocysteinaemia/homocystinuria in humans
11 (EMA, 2007). Betaine is not described in the 
European Pharmacopoeia. 
2.  Characterisation  
2.1.  Manufacturing process 
Betaine occurs naturally in sugar beets. The betaine under application is produced from genetically 
modified sugar beet H7-1(KM-ØØØH71-4) using the conventional methods for processing. Betaine is 
obtained  by  separation  from  molasses  and  crystallisation.  The  applicant  provided  a  detailed 
description of the manufacturing process, including a flow chart.  
Placing on the market of food and feed produced from genetically modified sugar beet H7-1 (KM-
ØØØH71-4) has been authorised by Commission Decision 2007/692/EC.
12 
                                                       
10 Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. 
11 EMEA Product No. EMEA/H/C/000678; EU No. EU/1/06/379/001. 
12 Commission Decision 2007/692/EC of 24 October 2007 authorising the placing on the market of food and feed produced 
from genetically modified sugar beet H7-1 (KMØØØH71-4) pursuant to Regulation (EC) No 1829/2003 of the European 
Parliament and of the Council. OJ L 283, 27.10.2007, p. 69. Betaine anhydrous for all animal species 
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2.2.  Characteristics of the active substance 
Betaine  (International  Union  of  Pure  and  Applied  Chemistry  (IUPAC)  name:  N,N,N-
trimethylammonioacetate;  synonym:  1-carboxy-N,N,N-trimethylammonium  inner  salt)  is  a 
zwitterionic  quaternary  ammonium  compound.  It  is  identified  by  the  Chemical  Abstracts  Service 
(CAS) number 107-43-7 and the European Inventory of Existing Chemical Substances (EINECS) 
number 203-490-6. The structural formula of glycine betaine is shown in Figure 1. 
     
Figure 1:  Structural formula of glycine betaine  
The molecular formula of glycine betaine is C5H11NO2 and its molecular weight is 117.15. It has a pKa 
of 2.38 and a melting point of 293  C and shows a bulk density of 0.5–0.6 g/cm
3. It is fully soluble in 
water (160 g dissolves in 100 mL), soluble in methanol (55 g in 100 mL) and ethanol (8.7 g in 100 
mL), sparingly soluble in ether and slightly soluble in chloroform.  
Betaine anhydrous is a free-flowing, off-white to light crystalline and slightly hygroscopic powder 
with a characteristic odour. By specification, the active substance contains at least 97 % betaine and 
less than 1.5 % moisture. Analysis of five batches of the product showed an average (± SD) content of 
betaine anhydrous of 98.3 ± 0.3 % and 0.9 ± 0.1 % moisture.
13 
In three batches lead was in the range < 0.10–0.15 mg/kg, mercury < 0.01–0.02 mg/kg, cadmium was 
<  0.01  mg/kg  and  arsenic  <  0.1  mg/kg.  In  the  same  batches,  certificates  of  analysis  for  betaine 
anhydrous showed that pesticides were not detectable. Total polychlorinated dibenzo-p-dioxins and 
polychlorinated  dibenzofurans  (PCDD/Fs)  were  < 0.11 ng  WHO-PCDD/F-TEQ  (toxic 
equivalents)/kg, and PCBs < 0.37 ng WHO-PCB-TEQ/kg. Final formulations are also monitored for 
mycotoxins (aflatoxins, fumonisins,  ochratoxin  A,  zearalenone,  deoxynivalenol, T2  toxin and  HT2 
toxin).
14 Fumonisin B1 was detected in two samples (7 and 65 µg/kg, which is at least two orders of 
magnitude  below  the  guidance  values  of  Commission  Recommendation  2006/576/EC).
15All  other 
values were below the  quantification limits (limit of detection (LOD): 0.3 µg/kg for aflatoxins, 5.0 
µg/kg  for  fumonisin,  1.0  µg/kg  for  ochratoxin  A,  10  µg/kg  for  zearalenone,  200  µg/kg  for 
deoxynivalenol, 50 µg/kg T2 toxin and 10 µg/kg HT2 toxin). The absence of microbial contamination 
(Bacillus cereus, total coliforms, faecal coliforms, Staphylococcus aureus, Salmonella, Pseudomonas 
aeruginosa,  flat  sours  (e.g.  Bacillus  stearothermophilus),  total  thermophiles,  anaerobes  producing 
hydrogen sulphide, mesophiles, moulds and yeasts) was demonstrated for 11 batches of the additive.
16  
One batch of betaine anhydrous was analysed for particle size distribution  by sieving. The average 
particle size was 35 8.6  µm  and the particle fraction below  52.32  µm  was  0.35 %  (w/w).
17  No 
information was provided on dusting potential.  
2.3.  Stability and homogeneity 
Betaine anhydrous is hygroscopic. 
                                                       
13 Technical dossier/Section II/Annex 2.1. 
14 Technical dossier/Section II/Annexes 2.2–2.4. 
15 Commission recommendation of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin A,  T-2 and 
HT-2 and fumonisins in products intended for animal feeding. OJ L 229, 23.8.2006, p. 7. 
16   Technical dossier/Section II/Annexes 2.5. 
17 Technical dossier/Section II/Annex 2.7. Betaine anhydrous for all animal species 
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2.3.1.  Shelf-life 
Betaine  anhydrous  (three  batches,  stored  in  polyethylene  bottles)  was  shown  to  be  stable  for  24 
months at 25 °C or 40 °C.
18 
An additive containing betaine (96 %) and an anti-caking agent (1 % calcium stearate) was stored for 
36 months at 35–40 °C. Recovery was 97 % (one batch).
19 
2.3.2.  Stability of the additives when added to premixtures, feed and water for drinking 
Betaine (three batches) was incorporated at 100 g/kg in poultry premixture containing vitamins and 
trace elements but no choline chloride and stored at 25  C in polyethylene bottles. Losses after six 
months were 9 % on average.
14 
The stability of three batches of the additive was also examined in mash and pelleted feed for poultry 
(supplementation level 1 g/kg) when stored at 25 °C in polyethylene bottles. After three months, no 
losses were found in either type of feed. Feed processing (pelleting) did not affect initial betaine 
concentration.
14 
The stability of the additive in water was demonstrated when added at 500 mg/L and kept for 24 hours 
at 25 °C.
14 However,
 in the case of water for drinking, stability data are required for 48 hours. 
2.3.3.  Homogeneity 
Ten subsamples of six feed samples (mash and pelleted feeds, three betaine batches, 1 g betaine/kg) 
showed a mean coefficient of variation of betaine concentration of 8.1 % and 5.6 % in mash and 
pelleted feed, respectively.
13  
Betaine anhydrous is highly soluble in water and therefore homogeneity in water for drinking does not 
need to be demonstrated. 
2.4.  Physico-chemical incompatibilities in feed 
No physico-chemical incompatibilities or interactions have been reported between betaine anhydrous 
and feed materials, feed additives or carriers when the additive was added to premixtures and feed. No 
such incompatibilities or interactions are expected. 
2.5.  Conditions of use 
Betaine anhydrous is intended for use in all animal species and categories without maximum limit. It 
is intended to be administered via feed, either directly or through a premixture, or via water for 
drinking.  
The  applicant  reports  typical  levels  of  inclusion  for  betaine  anhydrous  which  show  maximum 
inclusion levels of 1 000 mg/L water for drinking in poultry and pigs, of 10 000 mg/kg complete feed 
for fish and 15 000 mg/kg for crustaceans. The maximum daily doses for dairy cows and calves are 50 
g  per  day,  corresponding  to  about  2 000  to  2 500  mg/kg  complete  feed  for  dairy  cows,  the 
concentration in feed for calves being considerably higher. 
2.6.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of betaine in 
animal feed. The Executive Summary of the EURL report can be found in Appendix A.  
                                                       
18 Technical dossier/Section II/Annex 2.10 and Supplementary information March 2013/Annex A. 
19 Technical dossier/Section II/Annex 2.11. Betaine anhydrous for all animal species 
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3.  Safety 
According to Regulation (EC) No 429/2008, tolerance, metabolism and residue, and toxicological 
(concerning  consumer  safety)  studies  are  not  required  for  vitamins,  pro-vitamins  and  chemically 
defined  substances  having  similar  effects  which  are  already  authorised  as  feed  additives  under 
Directive 70/524/EEC and which do not have the potential to accumulate, which the FEEDAP Panel 
considers is the case for betaine. However, these exemptions are generally set without prejudice to any 
request for supplementary  information  made  by  the  Authority  in  accordance with  Article 8(2)  of 
Regulation (EC) No 1831/2003. 
3.1.  Metabolism and toxicological studies 
3.1.1.  Absorption, distribution, metabolism and excretion 
Betaine is rapidly absorbed in the intestine and metabolised mainly in the liver. Bioaccumulation does 
not occur. The metabolism of betaine is reviewed in Appendix B. 
3.1.2.  Toxicological studies 
The opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA) included an 
extensive appraisal of available toxicity data (EFSA, 2005). Betaine was not genotoxic in a series of in 
vitro and in vivo assays (Salmonella reverse mutation assay, clastogenicity in human lymphocytes in 
vitro,  micronucleus  assay  after  oral  administration  to  mice).  In  repeated  toxicity  studies  in  rats, 
reversible fatty vacuolisation of hepatocytes was observed at oral doses of 900 mg/kg body weight 
(bw) per day or more, as the adverse effect occurring at the lowest intake level: a no observed adverse 
effect  level  (NOAEL)  had  not  been  identified.  The  NDA  further  noted  that  no  reproduction  and 
developmental toxicity studies were provided. 
The  FEEDAP  Panel  has  performed  a  search  of  the  scientific  literature  from  2005  up  to  2013 
(searching Medline
20 and Toxnet
21): although several papers have been published on the physiological 
effects  of  betaine  supplementation,  e.g.  on  methionine  or  cholesterol  metabolism,  no  relevant 
information on adverse effects in laboratory animals has been published. 
3.1.2.1.  Human studies 
The NDA Panel (EFSA, 2005) assessed a number of published clinical studies using betaine: although 
betaine appeared to be well tolerated, the NDA Panel noted that investigation of adverse effects was 
rather limited. The most reliable study was considered to be a placebo-controlled randomised study 
(Schwab et al., 2002) carried out in 42 obese subjects (22 in the treatment group and 20 in the control 
group) given betaine or placebo at a dose of 6 g/person per day for 18 weeks. The dose (corresponding 
to approximately 90 mg/kg bw in a 70-kg person) had no effect on most parameters measured, but 
resulted in a reduction in homocysteine, a slight decrease of diastolic blood pressure and increased 
low-density  lipoprotein  and  total  cholesterol  in  serum.  Since  such  physiological  and  biochemical 
changes  might  have  adverse  consequences  in  susceptible  people  (e.g.  with  common  problems 
regarding the control of blood pressure or cholesterol), a tolerable upper intake level (UL) could not be 
derived from this study. 
3.2.  Safety for the target species 
The NDA Panel concluded that results of the animal studies with laboratory rodents did not prove 
satisfactorily that betaine is safe and, consequently, a NOAEL for betaine could not be derived (EFSA, 
2005). Thus, uncertainties concerning the safety of betaine remain and the applicant was requested to 
perform a tolerance study with betaine in piglets. 
                                                       
20 Available online: http://www.ncbi.nlm.nih.gov/pubmed/ 
21 Available online: http://toxnet.nlm.nih.gov/ Betaine anhydrous for all animal species 
 
EFSA Journal 2013;11(5):3211  10 
A total of 320 cross-breed (Piétrain   (Landrace   Large White)) piglets (half females and half males) 
were  allocated  to  one  of  four  treatments  (four  replicates,  each  of  10  piglets  of  each  sex  per 
treatment).
22 Initial body weight of the 28-day-old piglets was 8.2 kg. A prestarter (for the first two 
weeks) and a starter diet (for the followin g four weeks), both based on wheat, barley and soybean 
meal, were offered ad libitum in pelleted form. The basal diets (containing an average of about 1 000 
mg betaine/kg) were supplemented with betaine (purity > 97 %) at levels of 0, 2 000 (the highest use 
level), 10 000 or 20 000 mg/kg feed (analytically confirmed). Zootechnical performance and mortality 
were monitored. Blood samples were collected from eight animals per treatment (one per pen) at the 
end  of  the  study  and  analysed  for  haematology  and  blood  biochemistry.  At  the  end  of  the  trial, 
necropsy  was  performed  on  six  animals  per  treatment.  Performance  data  were  analysed  as  a 
completely randomised block design by a general linear model (GLM) procedure.  
Nine animals in the control group (11.25 %), seven animals in each of the groups treated with the low 
and the intermediate levels (8.75 %) and five animals in the highest dose group (6.25 %) died during 
the study as a result of diarrhoea or meningitis. No significant differences (P > 0.05) were observed 
between the treatments in terms of feed intake (530, 506, 522 and 505 g/day), final body weight (23.8, 
23.2, 23.7 and 23.1 kg), daily weight gain (372, 359, 369 and 357 g/day) or feed to gain ratio (1.42, 
1.41, 1.42 and 1.41).  
No significant differences between treatments were observed in haematology parameters (except for 
monocytes, non-treatment related). 
The treatments had no effects on clinical biochemistry parameters except phosphorus and  alanine 
transaminase  (ALT).  Betaine  resulted  in  a  significant  dose-related  decrease  in  serum  phosphorus 
(14.8, 14.6, 13.8 and 13.0 mg/dL; P < 0.0005). Serum ALT was significantly decreased in the group 
receiving the highest betaine dose compared with the control group (39.2 vs. 52.6 U/L). Betaine levels 
in plasma and liver reflected the dietary betaine supply; however, a steady-state was reached at the 
intermediate betaine dose. Liver weight was not affected by treatment. Increased vacuolisation of 
hepatocytes was observed at the highest betaine dose (significantly different from control). 
3.2.1.  Conclusions on the safety of betaine in target species 
The conclusiveness of the tolerance study is reduced by the high mortality (28 out of 320 piglets) and 
the absence of a description of the procedure used to select animals for collection of blood samples 
and necropsy. 
Betaine  in  concentrations  up  to  10  times  the  use  level  (2 000  mg/kg  feed)  did  not  affect  the 
zootechnical performance of piglets during the six weeks of the study. The only biologically relevant 
effects observed were a dose-dependent decrease in serum phosphorus and increased hepatocellular 
vacuolisation at 10 times the use level. The latter finding appears to be in agreement with observation 
of the NDA Panel (EFSA, 2005) that subacute and subchronic toxicity studies have clearly shown that 
the  liver  is  the  main  target  organ  in  rats.  The  dose-related  effects,  more  pronounced  in  females, 
included  increased  liver  weight,  hepatocellular  vacuolisation  and  increased  serum  levels  of  liver 
enzymes. However, in the study on piglets, increased liver weight and increased liver enzymes were 
not observed. The data indicate that betaine at 10 times the use level is not tolerated.  
A small but significant decrease in serum phosphorus was observed even at five times the use level. 
Although there is no convincing interpretation of the effect of betaine on serum phosphorus, this effect 
is considered adverse, particularly considering the longer exposure time and the fact that betaine is 
supplied for all animal species.  
The  proposed  highest  use  level  of  betaine  (2 000  mg  supplemented  betaine/kg  complete  feed)  is 
considered safe for piglets with a margin of safety below 5. This conclusion is extended to all pigs and 
extrapolated to all animal species and categories (EFSA 2012a). 
                                                       
22 Technical dossier/Supplementary information January 2013. Betaine anhydrous for all animal species 
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3.3.  Safety for the consumer 
3.3.1.  Consumer exposure 
3.3.1.1.  Tolerable upper intake level 
In a repeated toxicity studies in rats, a NOAEL had not been identified (EFSA, 2005). Considering 
also  that  no  reproduction  and  developmental  toxicity  studies  were  provided,  the  NDA  could  not 
establish  an  acceptable  daily  intake  (ADI)  from  animal  data.  The  NDA  also  concluded  that  the 
available human data did not satisfactorily exclude the possibility of risk from the intake of 90 mg 
betaine/kg bw per day; thus, no UL could be established.  
Since  no  new  toxicological  studies  could  be  found,  there  is  no  reason  to  reconsider  the  above 
conclusions. 
3.3.1.2.  Consumer exposure 
Betaine is naturally present in foodstuffs. Dietary sources include fish, beets, legumes and wheat. The 
daily intake from natural sources  may range from about 500 mg (average) to 2 500 mg for high 
consumers of seafood and/or whole wheat (EFSA, 2005).  
Food of animal origin (except seafood) is a rather poor source of betaine. A conservative estimate
23 of 
the potential increase in daily betaine intake attributable to consumption of tissues of treated animals, 
for high consumers only,
24 gives values of between 200 and 300 mg per person. Considering these 
values in relation to the upper range of the total intake (2 500 mg/day) and the contribution of dietary 
choline to the endogenous betaine pool,  it would be unlikely that the use of betaine anhydrous as a 
feed additive up to a supplementation rate of 2 000 mg/kg complete feed would substantially increase 
consumer exposure. 
3.3.1.3.  Conclusions on the safety for the consumer 
The FEEDAP Panel concludes that the use of betaine as feed additive up to a supplementation rate of 
2 000 mg/kg complete feed is unlikely to pose any concern for consumer safety. 
3.4.  Safety for the user  
3.4.1.  Effects on the respiratory system 
No information was available on the dusting potential of the additive. However, particle size data did 
not indicate a potential for inhalation of betaine, since the fraction below 50 µm was lower than 1 %. 
Therefore, only a small amount of any dust produced would be expected to reach the respiratory 
surface of the lungs. In the absence of any information on the toxicity of the inhaled dust, it is not 
possible to exclude the possibility of dust being hazardous to exposed workers. 
3.4.2.  Effects on the eyes and skin 
No  data  have  been  provided  on  the  effects  on  eye and  skin  of  betaine  anhydrous. The applicant 
provided a material safety data sheet (MSDS) for betaine anhydrous
25 stating that betaine anhydrous 
may cause irritation to the skin and the eyes.  
                                                       
23 Assuming a dose-related increase in tissue (liver) levels derived from serum betaine in the tolerance study with piglets and 
data in sow milk after feed supplementation with 2 000 mg/kg (Ramis et al., 2011) and an intake of animal tissues of 395 
g/day and of milk of 1.5 L/day (see Guidance on consumer safety; EFSA, 2012b). Eggs were not taken into account 
because of their very low betaine content. 
24 European Food Safety Authority, 2011. Use of the EFSA Comprehensive European Food Consumption Database in 
Exposure  Assessment.  EFSA  Journal,  9(3):2097  [34  pp.].  doi:  10.2903/j.efsa.2011.2097.  Available  online: 
www.efsa.europa.eu/efsajournal.htm 
25 Technical dossier/Section II/Annex 2.6. Betaine anhydrous for all animal species 
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3.4.3.  Conclusions on user safety 
In the absence of data, betaine anhydrous should be considered as hazardous by inhalation, irritant to 
skin, eyes and mucous membranes and a skin sensitiser. 
3.5.  Safety for the environment 
Betaine is widely distributed in nature as an endogenous metabolite in most organisms, including 
microorganisms,  plants  and  animals.  The  betaine  content  of  feedingstuffs  ranges  from  below  the 
detection limit of 150 mg/kg in corn and soybean products to about 4 000–5 000 mg/kg in wheat and 
wheat middlings (see review by Eklund et al., 2005). The use of betaine in animal nutrition is not 
expected to substantially increase the concentration in the excreta and the environment. Consequently, 
the supplementation of feed with betaine anhydrous does not pose a risk to the environment. 
4.  Efficacy 
According  to  Regulation  (EC)  No  429/2008,  efficacy  studies  are  not  required  for  vitamins,  pro-
vitamins and chemically well-defined substances having similar effects which are already authorised 
as feed additives. 
The function of betaine as a methyl group donor has been well known for decades because it is a 
metabolite of choline in the transmethylation of homocysteine to methionine. However, betaine cannot 
be converted back to choline in animals (see Appendix B). A multitude of research has been dedicated 
to  whether  and  to  what  extent  betaine  could  replace  choline  and/or  methionine.  Methionine  and 
choline are essential nutrients, whereas betaine is not. Choline cannot be replaced in its essential 
functions (such as synthesis of phospholipids), but it can be replaced as a methyl donor. Methionine 
can theoretically be replaced by a carbon skeleton functioning as a methyl group acceptor (such as 
homocysteine) and as a methyl group donor. As a result, betaine can partially substitute for methionine 
only if enough methyl acceptors are available. In turn, if the number of methyl groups provided in the 
diet is less than the requirement, which is determined by several metabolic processes, betaine (like 
other methyl donors) may prevent increasing levels of homocysteine. 
There are insufficient data to speculate what level of methyl group requirement could be satisfied by a 
methyl donor. Therefore, the dietary adequacy of betaine is directly affected by the presence of both 
methionine and choline in the complete feed. Consequently, positive effects of supplementing diets 
with betaine are mostly seen in animals fed diets marginally deficient in methionine and/or choline. A 
long history of use confirms the potential of betaine anhydrous to improve zootechnical parameters in 
pigs and poultry.  
In  the  case  of  ruminants,  it  is  questionable  whether  and  to  what  extent  betaine  escapes  rumen 
fermentation to become available at the duodenum level. The few data available for fish indicate that 
betaine functions predominantly as a flavouring agent/attractant. Positive effects described for betaine 
during transfer of salmonids from sweet water to salt water (Beklevik and Polat, 1999) may be traced 
back to its osmoprotectant property.  
Owing to the long history of use and its established nutritional role in domestic animals, betaine 
anhydrous is regarded as an effective source of betaine. This conclusion includes the use of betaine 
anhydrous in water for drinking. The FEEDAP Panel concludes that betaine has a potential to become 
efficacious in all animal species and categories when administered via feed or water for drinking. Betaine anhydrous for all animal species 
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5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
26  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Betaine is safe for piglets at the maximum supplementation rate of 2000 mg/kg complete feed with a 
margin of safety below 5. This conclusion is extended to all pigs and extrapolated to all animal species 
and categories. 
The use of betaine as feed additive up to a supplementation of 2 000 mg/kg complete feed is unlikely 
to pose concerns for consumer safety. 
In the absence of data, betaine anhydrous should be considered as hazardous by inhalation, an irritant 
to skin and eyes and mucous membranes, and as a skin sensitiser. 
The supplementation of feed with betaine anhydrous does not pose a risk to the environment. 
Betaine has a potential to become efficacious in all animal species and categories when administered 
via feed or water for drinking. 
RECOMMENDATIONS 
The FEEDAP Panel notes that the above conclusions on the safety of betaine for the target animals 
and the consumers are based on a maximum supplementation rate of 2 000 mg/kg feed. The Panel 
therefore strongly recommends the introduction of a maximum content of 2 000 mg supplemental 
betaine/kg complete feed. The corresponding maximum concentration in water for drinking would be 
1000 mg/L for poultry, 700 mg/L for pigs and 250 mg/L for calves for rearing. 
Given the potential for the safe dose to be exceeded  the simultaneous use of supplemental betaine in 
feed and water for drinking should be avoided. 
Since stability of betaine in a vitamin trace element premixture containing choline chloride has not 
been demonstrated, its use in premixtures containing choline chloride should be avoided. 
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APPENDICES 
APPENDIX A 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for betaine
27 
In the current application authorisation is sought under articles 4(1) and 10(2) for Betaine anhydrous
1-3 
and Betaine hydrochloride
2 under the category/functional group 3(a) ‘nutritional additives’/‘vitamins, 
pro-vitamins and chemically well defined substances having similar effect’ according to Annex I of 
Regulation (EC) No 1831/2003. Authorisation is sought for the use of the feed additive for all animal 
species and categories. According to the Applicants, Betaine hydrochloride
2 is an off-white to white 
crystalline powder with a minimum purity of 93 %, while Betaine anhydrous
1,2 (produced either by 
chemical synthesis or extracted from non-genetically modified sugar beet) will be marketed in two 
forms: - as a brown liquid with a minimum content of 47 % Betaine anhydrous; or - as a free flowing 
crystalline  powder  with  a  minimum  purity  of  96 %.  Finally,  Betaine  anhydrous
3  (extracted  from 
genetically modified sugar beet) contains a minimum of 97 % Betaine anhydrous and maximum 1.5 % 
of moisture.  
The liquid forms of Betaine anhydrous are to be used in feedingstuffs only, while the powder forms of 
Betaine anhydrous and Betaine hydrochloride are intended to be used in premixtures or added directly 
into the feedingstuffs and water.  
Unlike the previous regulation, where the minimum or maximum concentrations of Betaine anhydrous 
and Betaine hydrochloride in feedingstuffs and water were not specified, Applicants
1 proposed the 
following concentration ranges for the Betaine anhydrous:  
- for the powder form: from 0.5 to 2 g/kg in water and feedingstuffs; and 
- for the liquid form: from 2 to 4 g/kg in feedingstuffs. 
For  the  determination  of  Betaine  anhydrous  and  Betaine  hydrochloride  in  the  feed  additive, 
premixtures, feedingstuffs and water the Applicants proposed two similar single-laboratory validated 
methods, based on High Performance Liquid Chromatography with refractive index detector (HPLC-
RI). Both methods are based on determination of betaine content with ion-exclusion chromatography, 
using a strong cation exchange column (sodium or calcium column). These methods do not distinguish 
two forms of feed additive. Applicant
1 submitted a full validation and verification report and provided 
the following performance characteristics: 
  for the feed additive: a precision (repeatability and intermediate precision) ranging from 
0.1 to 0.8 %; and a recovery rate (RRec) ranging from 94 to 101 %;  
  for  premixtures  (samples  with  contents  ranging  from  6  to  1000  mg/g):  
a precision ranging from 4.3 to 6.9 %; and RRec ranging from 94 to 102 %;  
  for  feedingstuffs  (samples  with  contents  ranging  from  0.7  to  100  mg/g):  
a precision ranging from 4.4 to 8.6 %; RRec ranging from 94 to 107 %; and a limit of 
quantification (LOQ) of 70 mg/kg feedingstuffs; and  
  for water: a precision ranging from 0.1 to 2.4 %; RRec ranging from 94 to 101 %; and LOQ 
of 80 mg/L water. 
                                                       
27 The full report is available on the EURL website: 
  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-2010-0174+0216+0253.pdf 
1  FAD-2010-0174; 
2 FAD-2010-216; 
3 FAD-2010-0253 Betaine anhydrous for all animal species 
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Based on the performance characteristics presented, the EURL recommends for official control the 
single-laboratory validated and further verified method, using HPLC-RI, as submitted by Applicant
1, 
to determine Betaine anhydrous and Betaine hydrochloride (expressed as total betaine) in the feed 
additives,  premixtures,  feedingstuffs  and  water,  within  the  concentration  range  covered  by  the 
experimental data.  
Furthermore,  the  EURL  identified  the  internationally  recognised  US  Pharmacopeia  31  Betaine 
Hydrochloride monograph for the determination of Betaine hydrochloride in the feed additive. The 
identification is based on IR absorption, while quantification is based on titration with 0.1 N perchloric 
acid. Even though no performance characteristics are provided, the EURL recommends (in addition) 
for official control the USP31 monograph based on titration with perchloric acid for the quantification 
of Betaine hydrochloride in the feed additive. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. Betaine anhydrous for all animal species 
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APPENDIX B  
Betaine – its physiological role, endogenous synthesis and metabolism 
Betaine is considered as a non-essential nutritive substance. The principal physiological role of betaine 
is as an osmolyte (osmoprotectant) and methyl donor (e.g. Du Vigneaud et al., 1946; Yancey et al., 
1982; Storch et al., 1991; Lang et al., 1998; Craig, 2004). 
In  the  endogenous  metabolism  choline  is  irreversibly  oxidised  to  betaine.  Both  betaine  and 
methyltetrahydrofolate  donate  methyl  groups  to  homocysteine  to  produce  methionine  and  yield 
dimethylglycine  and  tetrahydrofolate,  a  cobalamin-dependent  process.  Elevated  levels  of 
homocysteine in the blood of humans have been associated with increased risk of cardiovascular 
diseases  (EFSA,  2007).  The  demethylated  betaine  (dimethylglycine)  is  further  metabolised  to 
glycine/serine. Glycine is also a methyl donor in the one-carbon pool, the methyl being transferred to 
tetrahydrofolic acid. The metabolism of betaine is shown in Figure B1.  
Furthermore, betaine acts as an osmolyte because of its dipolar zwitterions and its high solubility in 
water ,reducing osmotic stress during heat and/or disease challenge. 
 
Figure B1:   Betaine metabolism 
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